期刊文献+

痰热清与常用输液配伍及与其他药物混合后的变化 被引量:13

Compatibility of Tanreqing Injection and Its Changes with Other Medicines
下载PDF
导出
摘要 目的:考察痰热清注射液与常用输液及药物配伍后的变化。方法:观察痰热清注射液与常用输液和药物配伍后的pH值、药物性状变化,用高效液相色谱法测定黄岑苷、绿原酸的含量变化。结果:痰热清注射液与pH值大于7.8的药物输液如阿莫西林/舒巴坦钠、碳酸氢钠电解质、奥美拉唑、地塞米松磷酸钠注射液等混合后颜色变暗棕色,黄岑苷和绿原酸含量下降;与pH值低于4.7的药物输液如维生素B6、奥硝唑、头孢噻肟钠、头孢唑林钠、头孢硫脒、头孢哌酮/舒巴坦钠、盐酸溴己新葡萄糖注射液等混合后产生白色浑浊,绿原酸等成分含量下降。结论:痰热清注射液宜用0.9%氯化钠注射液稀释后静脉滴注,与其他药物联合静脉滴注时,两种药液间应使用0.9%氯化钠注射液冲管或分开注射。 Objective: To examine the compatibility of Tanreqing injection and its changes with other medicines.Methods: The changes of characters and pH were observed.The content of baicalin and chlorogenic acid were determined by HPLC method.Results: When Tanreqing injection were mixed with transfusions(pH7.8),such as amoxicillin sodiumand/sulbactam sodium,dexamethasone sodium phosphate,sodium bicarbonate,omeprazole,it became dark brown,and the content of baicalin and chlorogenic acid declined.When it were mixed with transfusions(pH4.7) such as vitamin B6,ornidazole,cefotaxime sodium,cephazolin sodium,cefathiamidine,cefoperazone sodium/sulbactam sodium,it caused white turbidity,and the content of chlorogenic acid and other component declined.Conclusions: Tanreqing injection should be diluted by 0.9 % sodium chloride before intravenous injection.Combination of Tanreqing injection and other medicines for infusion should be applied through separate injection or flushed perfusion tube.
出处 《儿科药学杂志》 CAS 2013年第1期28-32,共5页 Journal of Pediatric Pharmacy
关键词 痰热清注射液 PH 黄岑苷 绿原酸 Tanreqing injection pH Baicalin Chlorogenic acid
  • 相关文献

参考文献2

二级参考文献5

共引文献5

同被引文献195

引证文献13

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部